Hydroxyurea gets DCGI nod for treatment of sickle cell anaemia
Hyderabad: The Drugs Controller General of India (DCGI) approved hydroxyurea for the treatment of sickle cell anaemia.
The CSIR-SCA Mission, coordinated by the CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB) with the help of…